Atrial remodelling and atrial fibrillation self-sustaining: the role of circulating circDGCR8

Yuanfeng Gao1, Ying Dong1, Nan Jiang2

  • 1Heart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, No. 8, Gongti South Road, Chaoyang District, Beijing 100020, China.

PubMed

Insights

Circular RNAs (circRNAs) like circDGCR8 may predict atrial fibrillation (AF) progression and recurrence after ablation. This study links circDGCR8 to atrial remodeling, offering a potential new biomarker for AF management.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Current prediction of atrial fibrillation (AF) progression and post-ablation recurrence lacks accuracy.
  • Atrial remodeling is a key factor in atrial cardiomyopathy and may influence AF progression and recurrence.
  • Identifying reliable biomarkers for AF is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify circular RNAs (circRNAs) associated with atrial remodeling.
  • To evaluate the predictive potential of identified circRNAs for AF progression and post-ablation recurrence.

Main Methods:

  • Differential expression analysis of plasma circRNAs in paroxysmal AF (PAF) versus persistent AF (PsAF) patients using microarray.
  • Validation of candidate circRNAs via qPCR, statistical, and bioinformatics analysis.
  • In vitro studies (gain/loss-of-function) on human atrial fibroblasts and correlation analysis with atrial fibrosis (low voltage zones).
  • Evaluation of circDGCR8 in two clinical cohorts for AF progression and recurrence prediction.

Main Results:

  • circDGCR8 was significantly upregulated in PsAF patients and in fibroblasts treated with angiotensin II.
  • circDGCR8 promoted atrial remodeling by enhancing collagen production and fibroblast proliferation, affecting IL-17 and TNF signaling pathways.
  • Higher circDGCR8 levels correlated with increased atrial fibrosis.
  • Elevated circDGCR8 levels predicted increased risk of AF progression and post-ablation recurrence in clinical cohorts.

Conclusions:

  • circDGCR8 is associated with atrial remodeling and may serve as a predictive biomarker for AF progression.
  • circDGCR8 shows potential as a predictive biomarker for post-ablation AF recurrence.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...